DE2803920C2 - - Google Patents

Info

Publication number
DE2803920C2
DE2803920C2 DE2803920A DE2803920A DE2803920C2 DE 2803920 C2 DE2803920 C2 DE 2803920C2 DE 2803920 A DE2803920 A DE 2803920A DE 2803920 A DE2803920 A DE 2803920A DE 2803920 C2 DE2803920 C2 DE 2803920C2
Authority
DE
Germany
Prior art keywords
ammonium sulfate
liquid
gradient
rotor
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2803920A
Other languages
German (de)
English (en)
Other versions
DE2803920A1 (de
Inventor
William Joseph Ambler Pa. Us Mcaleer
Edward Henry Telford Pa. Us Wasmuth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to DE19782803920 priority Critical patent/DE2803920A1/de
Publication of DE2803920A1 publication Critical patent/DE2803920A1/de
Application granted granted Critical
Publication of DE2803920C2 publication Critical patent/DE2803920C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Centrifugal Separators (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE19782803920 1978-01-30 1978-01-30 Verfahren zur gewinnung von hepatitis b-oberflaechenantigen Granted DE2803920A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19782803920 DE2803920A1 (de) 1978-01-30 1978-01-30 Verfahren zur gewinnung von hepatitis b-oberflaechenantigen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782803920 DE2803920A1 (de) 1978-01-30 1978-01-30 Verfahren zur gewinnung von hepatitis b-oberflaechenantigen

Publications (2)

Publication Number Publication Date
DE2803920A1 DE2803920A1 (de) 1979-08-02
DE2803920C2 true DE2803920C2 (enExample) 1987-12-03

Family

ID=6030720

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782803920 Granted DE2803920A1 (de) 1978-01-30 1978-01-30 Verfahren zur gewinnung von hepatitis b-oberflaechenantigen

Country Status (1)

Country Link
DE (1) DE2803920A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470795A1 (fr) * 1979-12-07 1981-06-12 Pasteur Institut Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951937A (en) * 1973-12-20 1976-04-20 The Community Blood Council Of Greater New York, Inc. Large scale purification of hepatitis type B antigen using polyethylene glycol
US4024243A (en) * 1975-06-16 1977-05-17 Merck & Co., Inc. Process for isolating hepatitis B antigen

Also Published As

Publication number Publication date
DE2803920A1 (de) 1979-08-02

Similar Documents

Publication Publication Date Title
DE60207848T2 (de) Verfahren zur herstellung von konzentrierten menschlichen immunoglobulinen für die therapeutische verwendung
DE2333883A1 (de) Verfahren zur herstellung von gereinigtem albumin durch anwendung einer thermokoagulation und das erhaltene gereinigte albumin
DE69127384T2 (de) Verfahren zur Reinigung von Immunserumglobulinen
EP0156961B1 (de) Verfahren zur Herstellung hochgereinigter, stromafreier, hepatitissicherer Human- und Tierhämoglobinlösungen
DE2927841C2 (de) Verfahren zur Herstellung einer biologischen Zusammensetzung zur Verwendung als Blutserum-Bezugszusammensetzung für diagnostische Analysezwecke
DE69428356T2 (de) Reinigung von plasmaproteinen
DE3112539A1 (de) Verfahren zur auftrennung von waessrigen proteingemischen
DE2801123A1 (de) Verfahren zur herstellung eines intravenoes applizierbaren serumeiweiss- praeparates
DE2854381A1 (de) Verfahren zur gewinnung des antihaemophilen faktors viii aus blut, blutplasma oder blutplasma-fraktionen
DE3782768T2 (de) Verfahren fuer die produktion von im wesentlichen reinem albumin.
DE2636757C2 (de) Verfahren zum Aufkonzentrieren und Reinigen des Antihämophiliefaktors
DE69829408T2 (de) Herstellungsverfahren einer virusfreien faktor viii-lösung durch filtration
DE102004044429A1 (de) Verfahren zur Entfernung von Fibronektin aus Plasmafraktionen
DE3686390T2 (de) Verfahren zur herstellung vom antihaemophilfaktor (ahf) durch kaeltefaellung und zur verbesserung der loeslichkeit des hergestellten ahf-produktes.
DE2837168A1 (de) Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung
DE3330770A1 (de) Verfahren zur pasteurisierung von humanplasma
EP0367840B1 (de) Verfahren zur Herstellung eines hochreinen, nicht infektiösen Antihämophiliefaktors mittels Chromatographie
DE3046565C2 (enExample)
DE3236126A1 (de) Verfahren zur herstellung von zur intravenoesen verabreichung geeignetem (gamma)-globulin
DE2803920C2 (enExample)
DE2734150C3 (de) Verfahren zur Herstellung von Human-Lysozympräparaten
DE2213682A1 (de) Verfahren zur Trennung von Blutkomponenten von anderen Komponenten
DE2703620C2 (de) Verfahren zur Herstellung eines Konzentrats des Antihämophiliefaktors
EP0343275A1 (de) Verfahren zur Herstellung eines hochreinen, virusfreien Antihämophiliefaktors mittels Chromatographie
DE2748520C2 (enExample)

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee